Regulations for Registration of Medicinal Products Article 92-1

Any person submitting the application specified in Paragraph 1 of the preceding article may remove any Chinese medicine materials or ingredients banned by the importing country from the formula listed in the license held for a domestically manufactured Chinese medicine and may use the revised formula as the formulation basis set forth in Subparagraph 4 of Paragraph 1 of the preceding article when applying for registration of the Chinese medicine, without being subject to the restrictions set forth in Paragraphs 1 and 2 of Article 75.The manufacturer listed in the drug license issued upon the registration specified in the preceding paragraph is limited to the one listed in the license for the domestically manufactured Chinese medicine specified in the preceding paragraph. However, this does not apply in the event of a change of the manufacturer in accordance with Paragraph 1 of Article 106 or Article 107.For applications for registration in accordance with Paragraph 1, the batch records required in Subparagraph 5 of Paragraph 1 of the preceding article may be replaced by the Manufacturing and Control Standard. Moreover, submission of the records of general inspection for finished products, testing report for finished products, and the identification test results (including chromatographic maps or other documents sufficient for confirmations), as set forth in Subparagraph 6 of Paragraph 1 of the preceding article, as well as the reports of stability tests, as set forth in Subparagraph 7, is not required.
中文原文 藥品查驗登記審查準則第92-1條
前條第一項申請人,得就輸入國禁用之中藥材或成分原料,自原持有該國產中藥許可證所載處方之處方依據中刪除,並以刪除後之處方作為前條第一項第四款之處方依據,申請中藥查驗登記,不受第七十五條第一項、第二項規定之限制。
前項查驗登記所核發藥品許可證記載之製造廠,以前項原國產中藥許可證所載之製造廠為限。
但依第一百零六條第一項或第一百零七條規定辦理變更製造廠者,不在此限。
依第一項規定申請查驗登記者,其應檢附之前條第一項第五款批次製造紀錄,得以製造管制標準書代之;並得免附前條第一項第六款成品一般檢查紀錄表、成品檢驗成績書、鑑別試驗結果(包括層析圖譜或其他足資確認之資料)及第七款安定性試驗報告。

English translation for reference only; the Chinese text prevails. Not legal advice.